Theblood is a legitimate Berlin-based health-tech startup (founded 2022) pioneering menstrual blood analysis for diagnostics, backed by approximately €1M in pre-seed funding (RoX Health) and research partnerships (Charité). However, the project submission contained significantly exaggerated and inaccurate claims regarding traction ('most people have used my product') and reach. While the scientific utility and market timing are excellent (Femtech/Diagnostics), the project is currently in the R&D/waitlist phase with minimal active user base, placing it in the 'Minimal Traction' calibration tier. The score reflects high potential utility dampened by early-stage maturity and poor submission quality.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline